Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]
Apply
Risvutatug Rezetecan vs. BSC
A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302]
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step